Higher nucleoporin-Importinβ affinity at the nuclear basket increases nucleocytoplasmic import

PLoS One. 2013 Nov 25;8(11):e81741. doi: 10.1371/journal.pone.0081741. eCollection 2013.

Abstract

Several in vitro studies have shown the presence of an affinity gradient in nuclear pore complex proteins for the import receptor Importinβ, at least partially contributing to nucleocytoplasmic transport, while others have historically argued against the presence of such a gradient. Nonetheless, the existence of an affinity gradient has remained an uncharacterized contributing factor. To shed light on the affinity gradient theory and better characterize how the existence of such an affinity gradient between the nuclear pore and the import receptor may influence the nucleocytoplasmic traffic, we have developed a general-purpose agent based modeling (ABM) framework that features a new method for relating rate constants to molecular binding and unbinding probabilities, and used our ABM approach to quantify the effects of a wide range of forward and reverse nucleoporin-Importinβ affinity gradients. Our results indicate that transport through the nuclear pore complex is maximized with an effective macroscopic affinity gradient of 2000 µM, 200 µM and 10 µM in the cytoplasmic, central channel and nuclear basket respectively. The transport rate at this gradient is approximately 10% higher than the transport rate for a comparable pore lacking any affinity gradient, which has a peak transport rate when all nucleoporins have an affinity of 200 µM for Importinβ. Furthermore, this optimal ratio of affinity gradients is representative of the ratio of affinities reported for the yeast nuclear pore complex--suggesting that the affinity gradient seen in vitro is highly optimized.

MeSH terms

  • Active Transport, Cell Nucleus*
  • Cell Nucleus / metabolism*
  • Models, Theoretical
  • Nuclear Pore Complex Proteins / metabolism*
  • Probability
  • beta Karyopherins / metabolism*

Substances

  • Nuclear Pore Complex Proteins
  • beta Karyopherins

Grants and funding

The authors have declared no current external funding sources for this study.